deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02489357

Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer

A Pilot Study of MK-3475 With Cryotherapy for Men With Newly Diagnosed Oligo-metastatic Prostate Cancer

Sponsor: National Cancer Institute (NCI)

Conditions Stage IV Prostate Cancer
Interventions Cryosurgery Degarelix Laboratory Biomarker Analysis Pembrolizumab
Updated 12 times since 2017 Last updated: Nov 11, 2021 Started: Dec 11, 2015 Primary completion: Nov 30, 2017 Completion: Nov 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02489357, this NA trial focuses on Stage IV Prostate Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 12 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotActive Not Recruiting~Jul 2018 – ~May 2019 · 10 months · monthly snapshotActive Not Recruiting~May 2019 – ~Apr 2020 · 11 months · monthly snapshotCompleted~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Dec 2021 — Dec 2022 [monthly]

    Completed NA

▶ Show 7 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  2. Apr 2020 — Jan 2021 [monthly]

    Completed NA

  3. May 2019 — Apr 2020 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  4. Jul 2018 — May 2019 [monthly]

    Active Not Recruiting NA

  5. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting NA

  6. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

  7. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Data source: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations